Torigen Sees Great Momentum in 2023
April has been such an exciting, whirlwind month for Torigen, but we could not be happier with the progress and momentum we are building as we close out the first third of 2023! We had so many big news announcements that we wanted to highlight them all in one place in the event that you missed anything.
Torigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement
In early April, we announced a Prefered Partner Agreement with Veterinary Management Groups (VMG), which is an opportunity for Torigen to provide VMG’s more than 2,000 member clinics with access to our experimental autologous prescription products and services. We are excited about this partnership and are looking forward to expanding our ability to deliver innovative companion animal cancer treatments to an even greater patient population.
Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadership
Earlier in April, we started dropping hints on social media of other exciting news that we had coming, and it was fun to see everyone’s guesses as to what it could be! Our biggest news of the month was that our headquarters have moved to 6 Executive Drive in Farmington! We had a wonderful ribbon cutting ceremony on the 24th and there was a great turnout from members of the community. The new HQ is a 7,800 square foot production facility featuring a state-of-the-art clean room.
“Our new space provides us with tremendous opportunity for growth as we continue to establish ourselves as a leader in companion animal immuno-therapeutics,” said Troy Gobbett, Vice President of Operational Excellence.
Another piece of April news was that we announced a big expansion of our team, which consisted of a Director of Equine Sales, a Senior Scientist, a Director of Corporate Accounts, two Business Development Managers, and two Executive Sales Consultants. In addition to new team members, we announced that two existing members have been promoted to executive leadership positions. Troy Gobbett has been promoted to Vice President of Operational Excellence and will continue to focus on improving Torigen’s operational and financial efficiency and enhancing customer satisfaction. Dr. Ryan Clauson has been promoted to Chief Innovation Officer where he will lead the company's innovation strategy.
“Troy and Ryan have demonstrated their expertise and ability to move complex projects forward in our fast-paced environment, along with their dedication to bringing Torigen to new heights,” added Ms. Kalinauskas. “We expect 2023 to be an extremely productive year for the company and I am delighted to have them join our Leadership Team.”
April was filled with many good events at Torigen, but 2023 is still young! We have more events and growth to look forward to as we prepare to launch a new product line later this year and continue to develop and optimize our current offering.